LORD, ABBETT & CO. LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2019$6,724,000
-66.9%
76,862
-62.2%
0.02%
-70.3%
Q4 2018$20,326,000
+292.2%
203,158
+56.4%
0.07%
+516.7%
Q3 2013$5,182,000
-86.4%
129,928
-85.9%
0.01%
-86.4%
Q2 2013$38,030,000919,7000.09%
Other shareholders
HAEMONETICS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders